Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL2256576 | 0.85 | TSHR (0.50) | TSHRMMP1MMP3MMP8MEN1 | |
| Phosphoric Acid SCHEMBL29167359 | 0.85 | — | — | |
| Phosphoric Acid SCHEMBL5159836 | 0.81 | TSHR (0.46) | TSHRMMP1MMP3MMP8MEN1 | |
| Fluoride SCHEMBL27793708 | 0.80 | — | — | |
| Tetrahydrofuran SCHEMBL28066456 | 0.80 | ALDH1A1 (0.50) | MMP1MMP3MMP8 | |
| SCHEMBL10889963 | 0.76 | — | — | |
| SCHEMBL123363 | 0.76 | — | — | |
| SCHEMBL7053793 | 0.74 | — | — | |
| Phosphoric Acid SCHEMBL5067196 | 0.72 | — | — | |
| Phosphoric Acid SCHEMBL28768412 | 0.72 | TTR (0.42) | TSHRMMP1MMP3MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0898557-B9 | WATER SOLUBLE TRI-SUBSTITUTED 1,2-DIOXETANE COMPOUNDS HAVING INCREASED STORAGE STABILITY, SYNTHETIC PROCESSES AND INTERMEDIATES | LUMIGEN INC (US) | 2003-10-08 | — | — | EP | disclosed |
| EP-0898557-B1 | WATER SOLUBLE TRI-SUBSTITUTED 1,2-DIOXETANE COMPOUNDS HAVING INCREASED STORAGE STABILITY, SYNTHETIC PROCESSES AND INTERMEDIATES | LUMIGEN INC (US) | 2003-04-23 | — | — | EP | disclosed |
| US-6410751-B1 | GENERATING CHEMILUMINESCENCE | LUMIGEN, INC. | 2002-06-25 | — | — | US | disclosed |
| US-6353129-B1 | CHEMILUMINESCENCE | LUMIGEN, INC. | 2002-03-05 | — | — | US | disclosed |
| US-20020019553-A1 | Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates | AKHAVAN-TAFTI HASHEM (US) | 2002-02-14 | — | — | US | disclosed |
| US-6245928-B1 | ALKENE COMPOUNDS USED AS SYNTHETIC INTERMEDIATES IN THE PROCESS OF PREPARING DIOXETANES; WHICH ARE CHEMILUMINESCENT AND CAN BE USED AS NON-POLYMERIC CATIONIC SURFACTANT ENHANCER OR FLUORESCER | LUMIGEN, INC. | 2001-06-12 | — | — | US | disclosed |
| US-6180833-B1 | REACTING IN SOLVENT PRECURSOR VINYL ETHER WITH CATALYTIC AMOUNT OF MERCURY (II) SALT AND AT LEAST ONE MOLE EQUIVALENT OF ALCOHOL SELECTED FROM ALKANOLS, SUBSTITUTED ALKANOLS, BENZYL ALCOHOL AND UNSATURATED ALCOHOLS TO GIVE PRODUCT ETHER | LUMIGEN, INC. | 2001-01-30 | — | — | US | disclosed |
| EP-0898557-A4 | WATER SOLUBLE TRI-SUBSTITUTED 1,2-DIOXETANE COMPOUNDS HAVING INCREASED STORAGE STABILITY, SYNTHETIC PROCESSES AND INTERMEDIATES | LUMIGEN INC (US) | 2001-01-10 | — | — | EP | disclosed |
| US-6036892-A | ENZYMATICALLY TRIGGERED CHEMILUMINESCENT 1,2-DIOXETANES | LUMIGEN, INC. (US) | 2000-03-14 | — | — | US | disclosed |
| EP-0898557-A1 | WATER SOLUBLE TRI-SUBSTITUTED 1,2-DIOXETANE COMPOUNDS HAVING INCREASED STORAGE STABILITY, SYNTHETIC PROCESSES AND INTERMEDIATES | LUMIGEN, INC. (US) | 1999-03-03 | — | — | EP | disclosed |
| WO-1998019989-A1 | WATER SOLUBLE TRI-SUBSTITUTED 1,2-DIOXETANE COMPOUNDS HAVING INCREASED STORAGE STABILITY, SYNTHETIC PROCESSES AND INTERMEDIATES | LUMIGEN, INC. (US) | 1998-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019553-A1 | Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates | SMOX, FLAD1, FTO | TSHR 1265/4885MMP1 1053/4885MMP3 2129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.